Status:
UNKNOWN
Botulinum Toxin Augmented Surgery vs Conventional Surgery in the Management of Large Angle Horizontal Deviations
Lead Sponsor:
Assiut University
Conditions:
Large Angle Horizontal Strabismus
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
Horizontal strabismus includes esotropia and exotropia where there is inward or outward deviation of visual axes of the eyes respectively. The most common initial treatment of horizontal strabismus is...
Detailed Description
Strabismus is defined as inability of the two eyes to align their visual axes to a common object of regard. Horizontal strabismus may be in the form of esotropia or exotropia depending on whether the ...
Eligibility Criteria
Inclusion
- Large angle concomitant horizontal strabismus (\>50 prism diopters)
Exclusion
- Other neurologic, or developmental disorders
- Vertical deviation
- Significant A or V patterns
- Paralytic or restrictive forms of strabismus
- History of eye surgery (strabismus or otherwise)
Key Trial Info
Start Date :
February 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT03266549
Start Date
February 20 2021
End Date
November 30 2021
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmology department, faculty of medicine, Assiut university
Asyut, Egypt, 71526